UPMC, Nuance to develop language tools for EMRs

The University of Pittsburgh Medical Center (UPMC) and Nuance Communications will develop medical intelligence tools that improve the quality of care by creating an EMR across UPMC, with future plans to increase access to the general industry.

Signing a 10-year development agreement, the companies will create speech and clinical language understanding (CLU)-enabled technologies, according to Burlington, Mass.-based Nuance.

Under the terms of the agreement, Nuance and UPMC will focus initially on CLU technology and decision-support tools that will help clinicians capture relevant clinical details as they dictate notes for the medical record. Other areas being explored by the partnership include data mining specifically tied to the meaningful use requirements for electronic health records and creating tools that will allow clinical document repositories that can be searched and analyzed.

Technologies developed as part of the agreement will be commercially available through Nuance starting later this year, the company added.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.